Hostname: page-component-594f858ff7-pr6g6 Total loading time: 0 Render date: 2023-06-08T02:40:21.023Z Has data issue: false Feature Flags: { "corePageComponentGetUserInfoFromSharedSession": true, "coreDisableEcommerce": false, "corePageComponentUseShareaholicInsteadOfAddThis": true, "coreDisableSocialShare": false, "useRatesEcommerce": true } hasContentIssue false

Natural or vaccine-induced antibody as a predictor of immunity in the face of natural challenge with influenza viruses

Published online by Cambridge University Press:  15 May 2009

J. R. Davies
Public Health Laboratory Service, Influenza Research Unit, St Luke's Hospital, Warren Road, Guildford GUI 3NT
E. A. Grilli
Public Health Laboratory Service, Influenza Research Unit, St Luke's Hospital, Warren Road, Guildford GUI 3NT
Rights & Permissions[Opens in a new window]


HTML view is not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

A study of influenza in residential schools provided the opportunity to assess the significance of antibody as a predictor of immunity. Five hundred and fifty-six pupils from 8 schools were included in the investigations, and the outcome for these children in 27 naturally occurring outbreaks of influenza was analysed. The outbreaks comprised 5 caused by strains of influenza A H3N2, 10 caused by strains of influenza A H1N1, and 12 caused by strains of influenza B. On 8 occasions a second outbreak of the same serotype occurred in a school.

There was a general correlation between the presence of antibody to the outbreak strain and protection from infection. For each of the three influenza virus serotypes the infection rate in those with no detectable antibody was approximately 80%. Those with past experience of the virus but no antibody to the outbreak strain experienced lower infection rates (62% overall) but the infection rates were lowest in those with intermediate and high level antibody to the challenge strain (18% overall).

Vaccine was used by three of the schools. The effect of antibody derived from recent experience, either natural or vaccine-induced, on subsequent challenge with a drifted strain i.e. one showing antigenic drift away from the previous strain, was compared. Intermediate or high level antibody to the challenge strain in those who had experienced a recent natural infection was associated with a low infection rate (9%). A similar level of antibody produced in response to vaccination was associated with a significantly higher infection rate (23%:P 0-025). Among the vaccinees who had produced such antibody the infection rate was highest (32%) in those who had responded to vaccine in the presence of antibody to the vaccine strain.

The evidence from this study indicates that whilst antibody surveys of populations may provide some information about susceptibility to challenge with new strains of influenza viruses, the cirucumstances of the induction of the antibody affect its value as a predictor of immunity.

Research Article
Copyright © Cambridge University Press 1989



Al-Khayatt, R.Jennings, R. & Potter, C. W. (1984). Interpretation of responses and protective levels of antibody against attenuated influenza A viruses using single radial haemolysis. Journal of Hygiene 93, 301312.CrossRefGoogle ScholarPubMed
Cate, T. R., Couch, R. B., Parker, D. & Baxter, B. (1983). Reactogenicity, immunogenicity and antibody persistence in adults given inactivated influenza virus vaccine — 1978. Reviews of Infectious Disease 5, 737747.CrossRefGoogle ScholarPubMed
Chakraverty, P., Cunningham, P., Shen, G. Z. & Pereiba, M. S. (1986). Influenza in the United Kingdom 1982–1985. Journal of Hygiene 97, 347358.CrossRefGoogle Scholar
Delem, A. & Jovanovic, D. (1978). Correlation between rate of infection and pre-existing titer of serum antibody as determined by single radial haemolysis during an epidemic of influenza A/Victoria/3/75. Journal of Infectious Diseases 137, 194196.CrossRefGoogle Scholar
Grilli, E. A. & Davies, J. R. (1981). Infuenza B at Christ's Hospital: natural antibody to influenza B estimated by radial haemolysis. Journal of Hygiene 87, 211218.CrossRefGoogle Scholar
Grilli, E. A., Davies, J. R. & Smith, A. J. (1986). Infection with influenza A H1N1. 1.Production and persistence of antibody. Journal of Hygiene 96, 335343.CrossRefGoogle ScholarPubMed
Grilli, E. A. & Smith, A. J. (1983). The use of a radial haemolysis test for neuraminidase antibodies in the diagnosis of influenza A infection. Journal of Hygiene 91, 147156.CrossRefGoogle Scholar
Hobson, D., Curry, R. L., Beare, A. S. & Ward-Gardner, A. (1972). The role of serum haemugglutination-inhibition antibody in protection against challenge infection with A2 and B viruses. Journal of Hygiene 70, 767777.CrossRefGoogle ScholarPubMed
Jennings, R., Smith, T. L., Mellersh, A. R., Clark, A., Spencer, R. C. & Potter, C. W. (1985). Antibody response and persistence in volunteers following immunization with varying dosages of a trivalent surface antigen influenza virus vaccine. Journal of Hygiene 94, 8795.CrossRefGoogle ScholarPubMed
Oxford, J. S., Schild, G. C., Potter, C. W. & Jennings, R. (1979). The specificity of the antihaemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection. Journal of Hygiene 82, 5161.CrossRefGoogle Scholar
Pereira, M. S. & Chakraverty, P. (1977). The laboratory surveillance of influenza epidemics in the United Kingdom 1968–1976. Journal of Hygiene 79, 7787.CrossRefGoogle Scholar
Periera, M. S. & Chakraverty, P. (1982). Influenza in the United Kingdom 1977–1981. Journal of Hygiene 88, 501512.CrossRefGoogle Scholar
Smith, A. J. & Davies, J. R. (1976). Natural infection with influenza A (H3N2). The development, persistence and effect of antibodies to the surface antigens. Journal of Hygiene 77, 271282.CrossRefGoogle Scholar
Wesselius-de Casparis, A., Masurel, N. & Kerrebijn, K. F. (1972). Field trial with human and equine influenza vaccines in children: protection and antibody titres. Bulletin of the World Health Organization 46, 151157.Google ScholarPubMed
World Health Organization (1988). Recommended composition of influenza virus vaccines for use in the 1988–1989 season. Weekly Epidemiological Record 63, 5760.Google Scholar